How I treat adenovirus in hematopoietic stem cell transplant recipients
about
Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantationAdenovirus vectors for gene therapy, vaccination and cancer gene therapyAntiviral T-cell therapyAdvances in antivirals for non-influenza respiratory virus infections.HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.Adoptive immunotherapy with antigen-specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus-related respiratory failure in a child given haploidentical stem cell transplantation.Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantationAdenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovirAdenovirus infections in immunocompetent and immunocompromised patients.Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.Combinatorial targeting of 2 different steps in adenoviral DNA replication by herpes simplex virus thymidine kinase and artificial microRNA expression for the inhibition of virus multiplication in the presence of ganciclovirInhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative.Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamstersStrategies to harness immunity against infectious pathogens after haploidentical stem cell transplantationPharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipientsT-cell therapy for viral infections following transplantation: why stop at three viruses?Fatal fulminant hepatic failure from adenovirus in allogeneic bone marrow transplant patients.Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014Management of respiratory viral infections in hematopoietic cell transplant recipients.Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.Pre-Transplant Screening for Latent Adenovirus in Donors and Recipients.Performance Characteristics of FilmArray Respiratory Panel v1.7 for Detection of Adenovirus in a Large Cohort of Pediatric Nasopharyngeal Samples: One Test May Not Fit All.Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantationManagement of adenovirus in children after allogeneic hematopoietic stem cell transplantation.Immunotherapy for opportunistic infections: Current status and future perspectives.Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Diagnosis and treatment of adenovirus infection in immunocompromised patients.Accelerating immune reconstitution after hematopoietic stem cell transplantation.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.Umbilical cord blood graft engineering: challenges and opportunities.Suppression of Adenovirus Replication by Cardiotonic Steroids.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs.Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.A Rare Case of Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplant Patient.A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States.Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery.Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
P2860
Q26861648-4504781B-0785-4E38-9142-E22C392CCAA0Q27001601-E43E499B-C5DF-477B-92B2-04386A97FF04Q27028006-09E88FC6-64BA-487B-B923-8728F43E4FB4Q30457132-43798214-ACD8-45C4-BDB2-ECE8823D3AECQ32183133-4CF1165E-9C70-41E3-A82F-5B518DDC9D5AQ33410361-771F2CE2-4F7C-4B0D-A1AC-1B5E2B5A6E5CQ33559473-2E8703A6-52CA-4F75-BB31-8DA140B31E4AQ33566426-C2950302-631B-41CC-BE71-D2B46BED42F2Q33643453-34C91F57-055F-4F47-AC26-6C699082DF18Q34057627-0EBA0150-0A63-4FFB-AB01-1002F4768729Q34597872-5542CBA2-3A1C-4371-B725-4CBE19985AF1Q34791913-4B09F384-AB7F-4DAF-8DA5-C46EC3685FA8Q35183338-C7C49BA8-E606-4EF9-8F55-03ED5867F0C7Q35232836-02C282A7-D09B-44C0-BED3-C6ABB0D5ABD4Q35485612-140C99E5-EFB9-4F2C-B915-0D615E1C6F8DQ35746136-A279235B-E004-4AFC-B6FE-8A6E2F85A2B2Q36142522-FF852EED-AD79-462D-970B-346C1BF21283Q36184616-6EA154E3-55C9-4896-B526-048E3BB236F2Q36317622-AA60F7C3-E3F2-4B26-86C6-795C68B02A21Q36439896-24B0A45B-EFC2-4981-AD70-D6FE3C759639Q36445556-6DBB1705-3457-40DB-A23E-FA7F4C0F62F2Q36658623-2825E252-7977-416F-AC00-913A45188EAEQ36933090-812C5F2E-7A0D-49C9-8236-70FCA2063726Q36962653-C1DEFBB3-FF6D-4E4B-863E-70C328AA7F35Q37316282-C1E71AF0-DCF6-47F8-A0A9-1941026E6522Q37509216-822C50D5-5531-4BDB-AC53-CB935A9D0AC2Q37967604-DB5A9F8B-3636-4E27-8B5D-B1E595805F30Q38002109-49BB0F92-7911-4E4C-A0B8-BB1980B8F248Q38145327-4437CA19-B388-4BFA-A1DC-3CD23AB2C952Q38288125-B303865D-5D3C-481D-94D8-87ED25AABBD6Q38417056-C20885EE-E5E8-4E45-BF75-5C8F6DE941C1Q38514503-BB592A3E-FEDD-4598-96AF-556CE9FC9BB0Q38729229-6E57131E-7170-473D-81EE-511DBAB1D582Q39247468-C994391A-E078-4866-BE95-1C764C8AB284Q39249412-0CEAFC3D-FD0D-450B-BD46-9E3B9111F478Q39424154-29899266-13A9-480A-83E1-DC636D81D3ACQ40615759-B5BD4170-5216-4BE5-9086-81BF8D6D7BCEQ41564706-1F77B6F3-F66E-482C-9995-40BDA14C7842Q41904300-82B172E2-BBCE-4B29-8CBF-E5D23D55687BQ42176262-7CD0C847-BA56-4013-BB87-8A5E0482EF32
P2860
How I treat adenovirus in hematopoietic stem cell transplant recipients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How I treat adenovirus in hematopoietic stem cell transplant recipients
@en
How I treat adenovirus in hematopoietic stem cell transplant recipients.
@nl
type
label
How I treat adenovirus in hematopoietic stem cell transplant recipients
@en
How I treat adenovirus in hematopoietic stem cell transplant recipients.
@nl
prefLabel
How I treat adenovirus in hematopoietic stem cell transplant recipients
@en
How I treat adenovirus in hematopoietic stem cell transplant recipients.
@nl
P2860
P1433
P1476
How I treat adenovirus in hematopoietic stem cell transplant recipients
@en
P2093
Ann M Leen
Caroline A Lindemans
P2860
P304
P356
10.1182/BLOOD-2010-04-259291
P407
P577
2010-09-13T00:00:00Z